Updated indication expands treatment options for patients with ulcerative colitis and Crohn’s disease when tumor necrosis factor (TNF) blockers are clinically inadvisable
Celecoxib Capsules approval complements Strides’ existing products to serve a broader patient base
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies
Athos will perform multi-omic molecular and genetic analyses using biopsies from archived and de-identified Lahey IBD patient samples
The hybrid congress will take place from 1-4 June in Copenhagen, as well as virtually
Acquisition provides opportunity to develop cladribine in generalized Myasthenia Gravis (gMG) and Neuromyelitis Optica Spectrum Disorder (NMOSD)
Initiative seeks innovative experimental and computational approaches to uncover neural circuits regulating immune function and identify novel therapeutic targets
Under the agreement, Apogee shareholders will receive $135.11 per share in cash, and the transaction has been unanimously approved by both companies’ boards
The company will now distribute American Distilling’s range of natural specialty ingredients for use in cosmetics, personal care, and pharmaceutical applications across select EMEA markets
The collaboration aims to develop differentiated biologics that offer greater convenience and accessibility for patients
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
